Biotics Research Comments as FDA Addresses Fraudulent Claims

Products and Services

Rosenberg, Texas – May 3, 2017 – The FDA recently conducted an investigation of numerous websites searching for dietary supplement companies that are making cancer claims. The investigation resulted in the issuance of 14 Warning Letters. Following the Warning Letters, the FDA issued a Press Release prominently featuring pictures of products for which cancer claims had been made. One of the featured products in the Press Release, which was picked up by numerous media outlets, was Biotics Research’s Dysbiocide®.
 
It should be emphasized that Biotics Research Corporation did not receive a Warning Letter and has not been accused of making any inappropriate claims for its products, including Dysbiocide®.
 
The objectionable claims were not made by Biotics Research or any of its regional distributors but by a customer who allegedly made cancer claims for the product on its website. Of course making a claim for the cure, prevention, treatment, mitigation or diagnosis of cancer is clearly not allowed under the current law. Immediately upon learning of the dissemination of these inappropriate claims Biotics Research’s distributor terminated its relationship with the customer and has refused any further sales of Biotics Research’s products. If you have any questions regarding this matter contact Denis DeLuca (800-231-5777) at Biotics Research Corporation.
 
About Biotics Research Corporation
Biotics Research Corporation has been a leading manufacturer of specially designed nutritional supplements available through healthcare professionals for forty years. Our mission remains constant: to be the benchmark of excellence in nutritional science, technology and service, providing the clinician with reliable, innovative products of superior quality as well as the highest level of customer service. Visit www.BioticsResearch.com.
Razi Ann Berry
Author: Razi Ann Berry

Current Issue

Table of Contents

Trending Articles

PERQUE LLC introduces PERQUE DigestivAide™ Herbal Bitters.

ASHBURN, VA – PERQUE LLC announces the launch of PERQUE DigestivAide Herbal Bitters, a novel combination of angelica, burdock, dandelion, fennel, ginger, and yellow dock bitters to be taken before meals to stimulate appetite and promote healthy digestion. The...

Giving The Gift of Health This Holiday Season

Giving The Gift of Health This Holiday Season

US BioTek Is working with its practitioner network to provide free testing to those in need this holiday season Shoreline, WA, Nov. 10th— US BioTek Laboratories is working with its network of practitioners to provide free testing to those in need this holiday season....

Custom Publishing

Endogenous Stem Cell Mobilization With Dr. Mark Atkinson

Dr. Mark Atkinson presented on endogenous stem cell mobilization using botanical supplements from StemRogen, focusing on their core product StemRogen Release. He explained how stem and progenitor cells are mobilized from the bone marrow in response to tissue damage...

Quantum Energy Effects on Cell Recovery Rates

Quantum Energy Effects on Cell Recovery Rates

Author: Robert Sheaff, PhD, and Ian Mitchell Abstract This study investigated whether quantum field exposure generated by Leela Quantum Bloc Technology influences cell recovery rates in human cell lines. A series of double-blind experiments were conducted using Human...

Featured News